Back to search
Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive trials you may qualify forThis phase II clinical trial studies how well personalized natural killer (NK) cell therapy works after chemotherapy and umbilical cord blood transplant in trea…
The objective of this Phase II study is to assess the potential of asciminib in managing CML-CP or CML-AP in patient carrying the T315I mutation. The presence o…
This phase Ib trial tests the safety, side effects, and how well cytomegalovirus (CMV)-modified vaccinia Ankara (MVA) Triplex vaccine works in enhancing CMV-spe…
This phase II trial studies how well blinatumomab, methotrexate, cytarabine, and ponatinib work in treating patients with Philadelphia chromosome (Ph)-positive,…
This phase II trial studies the side effects and how well combination chemotherapy and ponatinib hydrochloride work in treating patients with acute lymphoblasti…
This phase II trial studies how well low-intensity chemotherapy and ponatinib work in treating patients with Philadelphia chromosome-positive and/or BCR-ABL pos…